Connection

AYSE MINDIKOGLU to Adult

This is a "connection" page, showing publications AYSE MINDIKOGLU has written about Adult.
Connection Strength

0.411
  1. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
    View in: PubMed
    Score: 0.035
  2. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47.
    View in: PubMed
    Score: 0.035
  3. Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List. Dig Dis Sci. 2016 Jan; 61(1):309-16.
    View in: PubMed
    Score: 0.030
  4. Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and?Dimethylarginines. Clin Gastroenterol Hepatol. 2016 Apr; 14(4):624-632.e2.
    View in: PubMed
    Score: 0.029
  5. Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc. 2014 Jan-Feb; 46(1):219-24.
    View in: PubMed
    Score: 0.026
  6. Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology. 2014 Apr; 59(4):1532-42.
    View in: PubMed
    Score: 0.026
  7. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int. 2012 Apr; 25(4):409-15.
    View in: PubMed
    Score: 0.023
  8. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010 Oct; 16(10):1147-57.
    View in: PubMed
    Score: 0.021
  9. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009 Jul; 15(7):719-29.
    View in: PubMed
    Score: 0.019
  10. Hepatitis C in the elderly: epidemiology, natural history, and treatment. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):128-34; quiz 124.
    View in: PubMed
    Score: 0.019
  11. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation. 2008 Feb 15; 85(3):359-68.
    View in: PubMed
    Score: 0.018
  12. HELLP syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy. Dig Dis Sci. 2006 Jul; 51(7):1206-12.
    View in: PubMed
    Score: 0.016
  13. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. Transplant Proc. 2006 Jun; 38(5):1440-4.
    View in: PubMed
    Score: 0.016
  14. Multiple normal deliveries in a woman with severe portal hypertension due to congenital hepatic fibrosis: the importance of preserved hepatocellular function. Am J Gastroenterol. 2005 Oct; 100(10):2359-61.
    View in: PubMed
    Score: 0.015
  15. Focal nodular hyperplasia in identical twins. Am J Gastroenterol. 2005 Jul; 100(7):1616-9.
    View in: PubMed
    Score: 0.015
  16. Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient. Chest. 2003 Mar; 123(3):956-8.
    View in: PubMed
    Score: 0.012
  17. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
    View in: PubMed
    Score: 0.009
  18. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
    View in: PubMed
    Score: 0.009
  19. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.009
  20. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700.
    View in: PubMed
    Score: 0.008
  21. End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection. J Viral Hepat. 2012 May; 19(5):371-6.
    View in: PubMed
    Score: 0.006
  22. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009 Dec; 15(12):1814-20.
    View in: PubMed
    Score: 0.005
  23. Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis. J Gastroenterol Hepatol. 2005 Jun; 20(6):882-9.
    View in: PubMed
    Score: 0.004
  24. Cardiovascular problems in cirrhotic patients. Turk J Gastroenterol. 2004 Sep; 15(3):126-32.
    View in: PubMed
    Score: 0.003
  25. Modulation of endothelial cell inflammatory integrins and stress markers with rh-factor VIIa in patients with advanced chronic hepatitis C. J Viral Hepat. 2003 Jul; 10(4):310-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.